Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Error in Title

Error in Title Letters OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. neck tumors in Figure 2 should reach 4% and 2%, respectively. In the Table, the 2016;17(2):174-183. doi:10.1016/S1470-2045(15)00467-2 study by Hussain et al has been added and the study by Kim et al has been de- leted. In Supplement 2, the PROSPER trial was deleted from eTable 1 and added 2. Martens MH, Maas M, Heijnen LA, et al. Long-term outcome of an organ to eTable 2. The ALTA trial was deleted from eTable 2. This article was corrected preservation program after neoadjuvant treatment for rectal cancer. J Natl online. Cancer Inst. 2016;108(12):djw171. doi:10.1093/jnci/djw171 1. Hilal T, Sonbol MB, Prasad V. Analysis of control arm quality in randomized 3. van der Valk MJM, Hilling DE, Bastiaannet E, et al; IWWD Consortium. clinical trials leading to anticancer drug approval by the US Food and Drug Long-term outcomes of clinical complete responders after neoadjuvant Administration [published online May 2, 2019]. JAMA Oncol. doi:10.1001/ treatment for rectal cancer in the international watch & wait database (IWWD): jamaoncol.2019.0167 an international multicentre registry study. Lancet. 2018;391(10139):2537-2545. doi:10.1016/S0140-6736(18)31078-X 4. Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait Correction to Conflict of Interest http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Error in Title

JAMA Oncology , Volume 5 (8) – Aug 1, 2019
Download PDF
1 page

Error in Title

Abstract

Letters OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. neck tumors in Figure 2 should reach 4% and 2%, respectively. In the Table, the 2016;17(2):174-183. doi:10.1016/S1470-2045(15)00467-2 study by Hussain et al has been added and the study by Kim et al has been de- leted. In Supplement 2, the PROSPER trial was deleted from eTable 1 and added 2. Martens MH, Maas M, Heijnen LA, et al. Long-term outcome of an organ to eTable 2. The ALTA trial was deleted from eTable...
Loading next page...
 
/lp/american-medical-association/error-in-title-RAf8eWIlqB

References (2)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2019.3304
Publisher site
See Article on Publisher Site

Abstract

Letters OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. neck tumors in Figure 2 should reach 4% and 2%, respectively. In the Table, the 2016;17(2):174-183. doi:10.1016/S1470-2045(15)00467-2 study by Hussain et al has been added and the study by Kim et al has been de- leted. In Supplement 2, the PROSPER trial was deleted from eTable 1 and added 2. Martens MH, Maas M, Heijnen LA, et al. Long-term outcome of an organ to eTable 2. The ALTA trial was deleted from eTable 2. This article was corrected preservation program after neoadjuvant treatment for rectal cancer. J Natl online. Cancer Inst. 2016;108(12):djw171. doi:10.1093/jnci/djw171 1. Hilal T, Sonbol MB, Prasad V. Analysis of control arm quality in randomized 3. van der Valk MJM, Hilling DE, Bastiaannet E, et al; IWWD Consortium. clinical trials leading to anticancer drug approval by the US Food and Drug Long-term outcomes of clinical complete responders after neoadjuvant Administration [published online May 2, 2019]. JAMA Oncol. doi:10.1001/ treatment for rectal cancer in the international watch & wait database (IWWD): jamaoncol.2019.0167 an international multicentre registry study. Lancet. 2018;391(10139):2537-2545. doi:10.1016/S0140-6736(18)31078-X 4. Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait Correction to Conflict of Interest

Journal

JAMA Oncology – American Medical Association

Published: Aug 1, 2019

There are no references for this article.